Innovative medications

With our experienced team of specialists and unique research infrastructure, the Jagiellonian Center of Innovation carries out a broad range of research for the companies involved in research and development of medications.

We offer:


Quantitative and qualitative research, including:

  • Development of chromatographic methods (liquid and gas chromatography, SFC)
  • Transfer of the method to the Client
  • Research using spectroscopy:
    • Mass spectrometry (MS)
    • NMR spectroscopy
    • Infrared (IR) spectroscopy
    • Raman spectroscopy
    • UV-VIS spectroscopy


Purification of chemical substances:

  • Development of chromatographic methods


Structural characterization of the substance using:

  • Mass spectrometry (QTOF): determination of molecular mass and amino acid sequence
  • NMR spectroscopy
  • Infrared (IR) spectroscopy
  • Raman spectroscopy
  • Protein electrophoresis


Characterization of pharmacological properties of the substance:

  • Molecular screening (SPR, MST)
  • Molecular target validation
  • Cell testing
  • Animal testing


Analysis of crystallographic structures (polymorphism) with the use of:

  • Infrared (IR) spectroscopy
  • Raman spectroscopy
  • Powder diffractometry (XRPD / XRD)

Development Specialist

Małgorzata Szczepańska


Ms Małgorzata Szczepańska holds a master’s degree in pharmacy. She received her degree from the Medical University of Lublin, Faculty of Pharmacy, where she also pursued a specialization in industrial pharmacy. She has also completed a postgraduate program in clinical nutrition at the Medical University of Warsaw. Ms Szczepańska has gained her professional experience working for one of Poland’s leading pharmaceutical companies. She has been involved with the Jagiellonian Center of Innovation since 2019; her responsibilities include, amongst others, liaising with clients as regards support for research and development processes in pharmacy.


For a quote, please contact:

Telephone: +48 12 297 46 77

Mobile: +48 501 108 058

This website uses cookies. By continuing to use it, you consent to our use of cookie files.